Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease

BACKGROUND: Mesenchymal stromal cell (MSC)-based therapy is a promising strategy for preventing the progression of chronic kidney disease (CKD), with the potential to induce tissue regeneration. In search of the best cellular source we compared, in the rat model of adriamycin (ADR) nephropathy, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rota, Cinzia, Morigi, Marina, Cerullo, Domenico, Introna, Martino, Colpani, Ornella, Corna, Daniela, Capelli, Chiara, Rabelink, Ton J., Leuning, Danielle G., Rottoli, Daniela, Benigni, Ariela, Zoja, Carlamaria, Remuzzi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092807/
https://www.ncbi.nlm.nih.gov/pubmed/30107860
http://dx.doi.org/10.1186/s13287-018-0960-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092807/
https://www.ncbi.nlm.nih.gov/pubmed/30107860
http://dx.doi.org/10.1186/s13287-018-0960-8

Ejemplares similares